These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20874491)

  • 21. Down-regulation of connexin 32 gene expression through DNA methylation in a human renal cell carcinoma cell.
    Hirai A; Yano T; Nishikawa K; Suzuki K; Asano R; Satoh H; Hagiwara K; Yamasaki H
    Am J Nephrol; 2003; 23(3):172-7. PubMed ID: 12690227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of microRNA expression in renal cell carcinoma.
    Schiffgen M; Schmidt DH; von Rücker A; Müller SC; Ellinger J
    Biochem Biophys Res Commun; 2013 Jun; 436(1):79-84. PubMed ID: 23707942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
    Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M
    Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
    Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features.
    Wang L; Cui Y; Zhang L; Sheng J; Yang Y; Kuang G; Fan Y; Zhang Q; Jin J
    PLoS One; 2016; 11(9):e0161859. PubMed ID: 27583477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.
    Yamada D; Kikuchi S; Williams YN; Sakurai-Yageta M; Masuda M; Maruyama T; Tomita K; Gutmann DH; Kakizoe T; Kitamura T; Kanai Y; Murakami Y
    Int J Cancer; 2006 Feb; 118(4):916-23. PubMed ID: 16152585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target.
    Liu Q; Jin J; Ying J; Cui Y; Sun M; Zhang L; Fan Y; Xu B; Zhang Q
    Oncotarget; 2015 Sep; 6(26):22706-23. PubMed ID: 26093088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.
    Sturm I; Stephan C; Gillissen B; Siebert R; Janz M; Radetzki S; Jung K; Loening S; Dörken B; Daniel PT
    Cell Death Differ; 2006 Apr; 13(4):619-27. PubMed ID: 16322756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
    Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
    Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
    Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide promoter methylome of small renal masses.
    Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
    PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
    Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
    Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.